Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Acalabrutinib, bortezomib and ibrutinib for treating mantle cell lymphoma
Withdrawn

Acalabrutinib, bortezomib and ibrutinib for treating mantle cell lymphoma

Condition

Cancer

Blood and Immune System

2 January 2024

Published on 12 Jul 2022
Last Updated on 02 Jan 2024

Acalabrutinib, bortezomib and ibrutinib for treating mantle cell lymphoma Guidance is outdated and has been withdrawn on 2 Jan 2024. 

The Plain English Summary (PES) has been updated on 2 Jan 2024.

Acalabrutinib, bortezomib and ibrutinib for treating mantle cell lymphoma (Withdrawn 2 Jan 2024) [PDF, 196 KB]

PES Treatments for mantle cell lymphoma (Updated 2 Jan 2024) [PDF, 150 KB]

Back to top